How will rescheduling cannabis impact pot stocks? Dan Ahrens expects a domino effect of various federal level reforms to clarify medical and adult use legality. The MSOS ETF is strongly positive year-to-date and is beating both the Nasdaq and S&P by more than three times. Morgan Paxhia weighs in on a possible reclassification of marijuana.